Company Filing History:
3 out of 4,455 
1 out of 832,812 Years Active: 2001-2007
Title: Inventor Profile: Brian T Suiter
Introduction: Brian T Suiter is an accomplished inventor based in Lincoln, Nebraska, renowned for his contributions to the fields of immunology and veterinary medicine. With a total of four patents to his name, Suiter's innovations are pivotal in enhancing vaccine formulations and providing long-term protection against various animal diseases.
Latest Patents: Brian T Suiter's latest patents showcase his commitment to advancing veterinary health. One of his notable inventions relates to stabilized antigen compositions and vaccine formulations that effectively provide long-term protection against erysipelas in animals. Additionally, he has developed a patent focused on five novel, low molecular weight proteins derived from Actinobacillus pleuropneumoniae, which induce protective immune responses in swine. This invention also encompasses polynucleotide molecules that encode these proteins, as well as the associated vaccines and methods of their application.
Career Highlights: Throughout his career, Brian T Suiter has made significant strides in the pharmaceutical industry. He has worked with Pfizer Corporation, where he has further refined his expertise in vaccine development and immunology. His innovative approach and dedication to veterinary science have led to impactful advancements in animal healthcare.
Collaborations: Suiter's collaborative efforts have also included working alongside esteemed colleagues such as Timothy J Miller and Albert Paul Reed. These partnerships have played a critical role in the research and development of his patented inventions, enhancing the potential impact of his work on animal health.
Conclusion: Brian T Suiter exemplifies the spirit of innovation in the field of veterinary medicine. His patented inventions contribute greatly to the health and well-being of animals, ensuring they receive the best possible protection against diseases. As he continues to develop advanced immunological solutions, Suiter's work will undoubtedly shape the future of veterinary vaccine formulations.